SELECT A FORMAT

Single User Electronic (PDF)

Site License Electronic (PDF)

Enterprisewide Electronic (PDF)

order by fax need a quote ?

HAVE A QUESTION?

EMAIL US VIEW FAQs

TESTIMONIALS

The Service I received from the Orders and Customer Service Team was very professional. Their responses were very quick and actioned on immediately.

Mr Gueorgui Tzvetanov Senior Manager ERGO Austria International AG
The Research and Markets’ customer support team provided me with timely and immediate responses and delivered exactly the information that I was looking for – great job. Thank you very much. I would recommend them to anybody who is looking for market research data.

Ms Iris Teichmann Head of Marketing & Communications Berliner Glas KGaA Herbert Kubatz GmbH & Co.
Great customer service and super responsive. I was having issues with my payment method but Claire in customer service was super responsive to help several times until the issue was entirely resolved. Great job

Mr Detlef Rethage President Nitto Avecia Inc
The reports ordered are of good quality and are relevant to our business needs.

Mr Etienne Adriansen Senior Director Business Evaluation LEO Pharma
Thank you for all of your help! I think your service is excellent. It is an easy platform to order interesting reports.

Mr Tomi Amberla Consultant Pöyry Management Consulting
The team at Research and Markets are first rate. Their market intelligence is relevant and accurate and the customer service fast, responsive and dependable. I always benefit from knowledge gained from their comprehensive studies and will continue to utilize their services.

Ms Liz Dickinson CEO Physical Enterprises Inc
I have bought reports from other sources but the report that I bought from Research and Markets was the most detailed of the lot. Their customer service was excellent and I was able to get the report without any fuss.

Mr Naveed Kamal Asst Manager: Business Development Rangs Group Ltd

Antares Pharma Inc (ATRS) - Financial and Strategic SWOT Analysis Review

ID: 4315239
SWOT Analysis
46 pages
GlobalData
Antares Pharma

DESCRIPTION
TABLE OF CONTENTS
SAMPLES
COMPANIES MENTIONED
FORMATS / FAQ

1 of 5

FEATURED COMPANIES

AbbVie Inc
Accord Healthcare Inc
Bedford Laboratories
Endo Pharmaceuticals Inc
Fresenius Kabi USA LLC
Hospira Inc
MORE

Antares Pharma Inc (ATRS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description - A detailed description of the company’s operations and business divisions.
Corporate strategy - Analyst’s summarization of the company’s business strategy.
SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
Company history - Progression of key events associated with the company.
Major products and services - A list of major products, services and brands of the company.
Key competitors - A list of key competitors to the company.
Key employees - A list of the key executives of the company.
Executive biographies - A brief summary of the executives’ employment history.
Key operational heads - A list of personnel heading key departments/functions.
Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
Key manufacturing facilities - A list of key manufacturing facilities of the company.
Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Antares Pharma Inc (Antares Pharma) is a specialty pharmaceutical company that focuses on development and commercialization of self-injection pharmaceutical drugs and technologies and topical gel-based products. The company has product OTREXUP which is an injection for subcutaneous which is approved by FDA for the treatment of adults with severe active rheumatoid arthritis and QuickShot which is a testosterone for testosterone replacement therapy. The company has an injection technology platform which includes VIBEX which is disposable pressure-assisted auto injectors. The company has multiple development partnerships with various pharmaceutical companies. It has a presence in New Jersey, Switzerland and Minnesota. Antares Pharma is headquartered in Ewing, New Jersey, the US.

Antares Pharma Inc Key Recent Developments

May 09,2017: Antares Pharma Reports First Quarter 2017 Operating and Financial Results
Mar 14,2017: Antares Pharma Reports Fourth Quarter and Full Year 2016 Operating and Financial Results
Nov 09,2016: Antares Pharma Reports Third Quarter 2016 Financial and Operating Results
Oct 31,2016: Antares Pharma Appoints Fred M. Powell, Senior Vice President and Chief Financial Officer
Aug 09,2016: Antares Pharma Reports Second Quarter 2016 Operating and Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Note: Product cover images may vary from those shown

2 of 5

FEATURED COMPANIES

AbbVie Inc
Accord Healthcare Inc
Bedford Laboratories
Endo Pharmaceuticals Inc
Fresenius Kabi USA LLC
Hospira Inc
MORE

Section 1 - About the Company
Antares Pharma Inc - Key Facts
Antares Pharma Inc - Key Employees
Antares Pharma Inc - Key Employee Biographies
Antares Pharma Inc - Major Products and Services
Antares Pharma Inc - History
Antares Pharma Inc - Company Statement
Antares Pharma Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis
Antares Pharma Inc - Business Description
Antares Pharma Inc - SWOT Analysis
SWOT Analysis - Overview
Antares Pharma Inc - Strengths
Antares Pharma Inc - Weaknesses
Antares Pharma Inc - Opportunities
Antares Pharma Inc - Threats
Antares Pharma Inc - Key Competitors

Section 3 - Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Ratio Charts

Section 4 - Company’s Lifesciences Financial Deals and Alliances
Antares Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Antares Pharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Antares Pharma Inc, Recent Deals Summary

Section 5 - Company’s Recent Developments
May 09, 2017: Antares Pharma Reports First Quarter 2017 Operating and Financial Results
Mar 14, 2017: Antares Pharma Reports Fourth Quarter and Full Year 2016 Operating and Financial Results
Nov 09, 2016: Antares Pharma Reports Third Quarter 2016 Financial and Operating Results
Oct 31, 2016: Antares Pharma Appoints Fred M. Powell, Senior Vice President and Chief Financial Officer
Aug 09, 2016: Antares Pharma Reports Second Quarter 2016 Operating and Financial Results
May 09, 2016: Antares Pharma Reports First Quarter 2016 Operating and Financial Results
Mar 08, 2016: Antares Pharma Reports Fourth Quarter and Full Year 2015 Operating and Financial Results
Jan 26, 2016: Antares Pharma Announces CEO Transition

Section 6 - Appendix
Methodology
Ratio Definitions
About
Contact
Disclaimer

List of Tables
Antares Pharma Inc, Key Facts
Antares Pharma Inc, Key Employees
Antares Pharma Inc, Key Employee Biographies
Antares Pharma Inc, Major Products and Services
Antares Pharma Inc, History
Antares Pharma Inc, Other Locations
Antares Pharma Inc, Subsidiaries
Antares Pharma Inc, Key Competitors
Antares Pharma Inc, Ratios based on current share price
Antares Pharma Inc, Annual Ratios
Antares Pharma Inc, Annual Ratios (Cont...1)
Antares Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Antares Pharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Antares Pharma Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Antares Pharma Inc, Performance Chart (2012 - 2016)
Antares Pharma Inc, Ratio Charts
Antares Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Antares Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017

Note: Product cover images may vary from those shown

3 of 5

LOADING...

4 of 5

Teva Pharmaceutical Industries Ltd
Roxane Laboratories Inc
Mylan Inc
Medac Inc
Hospira Inc
Fresenius Kabi USA LLC
Endo Pharmaceuticals Inc
Bedford Laboratories
Accord Healthcare Inc
AbbVie Inc

Note: Product cover images may vary from those shown

5 of 5

Note: Product cover images may vary from those shown

License	Format	Properties	Price
SINGLE USER Electronic (PDF)	The report will be emailed to you. The report is sent in PDF format.	This is a single user license, allowing one specific user access to the product.	€105EUR$125USD£91GBP
SITE LICENSE Electronic (PDF)	The report will be emailed to you. The report is sent in PDF format.	This is a site license, allowing all users within a given geographical location of your organisation access to the product.	€209EUR$250USD£182GBP
ENTERPRISEWIDE Electronic (PDF)	The report will be emailed to you. The report is sent in PDF format.	This is an enterprise license, allowing all employees within your organisation access to the product.	€314EUR$375USD£274GBP

FEATURED COMPANIES

FEATURED COMPANIES

PRODUCT CATEGORIES

RELATED PRODUCTS

Antares Pharma, Inc. (ATRS) - Financial and Strategic SWOT Analysis Review

Antares Pharma, Inc. - Strategy, SWOT and Corporate Finance Report

Antares Pharma, Inc. - Product Pipeline Review - 2015

Antares Pharma Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

Antares Pharma Inc. Company Profile - Business Strategies, Outlook Statement, Business Description, Products and Services, Competitors, Employees, Updates, SWOT and Financials

YOUR QUESTION*

YOUR CONTACT DETAILS*